{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:01:54Z","timestamp":1752278514780,"version":"3.41.2"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"08","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82073710"],"award-info":[{"award-number":["82073710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Double-First-Class University Project","award":["CPU2022PZQ01"],"award-info":[{"award-number":["CPU2022PZQ01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Planta Med"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tanshinone \u2161A (TSA), a component of traditional Chinese medicine, effectively protects against myocardial injury. However, its clinical application is limited by poor water solubility and a short half-life. In this study, we report on four TSA derivatives designed and synthesized by our research group. The protective activity against hypoxia-reoxygenation injury in cells was evaluated, and derivative \u2160-3 was selected for in vivo experiments to verify its myocardial protective activity in rats with myocardial infarction. The results demonstrated that these four compounds could protect neonatal rat cardiomyocytes from hypoxia-reoxygenation injury. Among the derivatives, \u2160-3 showing superior protective effects, we found that \u2160-3 has enhanced metabolic stability and an extended half-life. \u2160-3 exhibited superior biological activity, effectively reducing the heart infarction area, alleviating myocardial hypertrophy, and enhancing cardiac pumping function. \u2160-3 reported in\n          the present work represents a novel and effective derivative of TSA, showing great potential for the treatment of myocardial ischemia (MI).<\/jats:p>","DOI":"10.1055\/a-2565-8285","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:13:32Z","timestamp":1742847212000},"page":"451-460","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury"],"prefix":"10.1055","volume":"91","author":[{"given":"Zhiwu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P.\u200aR. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P.\u200aR. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, China Pharmaceutical University, Nanjing, P.\u200aR. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, China Pharmaceutical University, Nanjing, P.\u200aR. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-3845","authenticated-orcid":false,"given":"Jinxin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, China Pharmaceutical University, Nanjing, P.\u200aR. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, P.\u200aR. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"volume-title":"World Health Statistics 2024: Monitoring Health for the SDGs, Sustainable Development Goals","year":"2024","author":"WHO","key":"ref1"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3967\/bes2022.079","article-title":"Report on cardiovascular health and diseases in China 2021: An updated summary","volume":"35","author":"Writing committee of the report on cardiovascular health and diseases in China","year":"2022","journal-title":"Biomed Environ Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/clc.20871","article-title":"Myocardial ischemia is not always due to epicardial atheromatous disease","volume":"34","author":"C Richard Conti","year":"2011","journal-title":"Clin Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3389\/fimmu.2018.02031","article-title":"Stress and inflammation in coronary artery disease: A review psychoneuroendocrineimmunology-based","volume":"9","author":"M Fioranelli","year":"2018","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2174\/1381612822666161010105242","article-title":"Salvia miltiorrhiza: A potential red light to the development of cardiovascular diseases","volume":"23","author":"L Wang","year":"2017","journal-title":"Curr Pharm Des"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"176523","DOI":"10.1016\/j.ejphar.2024.176523","article-title":"Sodium tanshinone IIA sulfonate suppresses microglia polarization and neuroinflammation possibly via regulating miR-125b-5\u2009p\/STAT3 axis to ameliorate neuropathic pain","volume":"972","author":"J Zeng","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"105661","DOI":"10.1016\/j.phrs.2021.105661","article-title":"Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases","volume":"169","author":"L Subedi","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11011-022-00911-y","article-title":"Sodium tanshinone IIA sulfonate improves cognitive impairment via regulating A\u03b2 transportation in AD transgenic mouse model","volume":"37","author":"H H Ma","year":"2022","journal-title":"Metab Brain Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"155431","DOI":"10.1016\/j.phymed.2024.155431","article-title":"Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer","volume":"128","author":"Y Z Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12906-024-04363-y","article-title":"Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K\/Akt pathway in small cell lung cancer cells","volume":"24","author":"Y Jiang","year":"2024","journal-title":"BMC Complement Med Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/ijmm.2023.5312","article-title":"Tanshinone IIA confers protection against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1","volume":"52","author":"T Hu","year":"2023","journal-title":"Int J Mol Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1536\/ihj.23-087","article-title":"Tanshinone IIA regulates MAPK\/mTOR signal-mediated autophagy to alleviate atherosclerosis through the miR-214-3\u2009p\/ATG16L1 Axis","volume":"64","author":"Y Qian","year":"2023","journal-title":"Int Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/antiox9090857","article-title":"Overview of Salvia miltiorrhiza as a potential therapeutic agent for various diseases: An update on efficacy and mechanisms of action","volume":"9","author":"I Jung","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"05","key":"ref14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhiza Burge (Danshen): A golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Z M Li","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2007.04.031","article-title":"Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis","volume":"568","author":"J Fu","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.trsl.2007.11.005","article-title":"Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis","volume":"151","author":"J Gao","year":"2008","journal-title":"Transl Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1753944710396538","article-title":"Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways","volume":"5","author":"C Pan","year":"2011","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1142\/S0192415X11008890","article-title":"Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts","volume":"39","author":"P Chan","year":"2011","journal-title":"Am J Chin Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2014.12.016","article-title":"Calcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow","volume":"80","author":"N D Andersen","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajps.2016.08.004","article-title":"Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones","volume":"12","author":"X Zhai","year":"2017","journal-title":"Asian J Pharm Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1055\/s-2006-951698","article-title":"Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion","volume":"72","author":"H Hao","year":"2006","journal-title":"Planta Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1875-5364(18)30037-2","article-title":"Synthesis and biological evaluation of novel tanshinone IIA derivatives for treating pain","volume":"16","author":"Q N Li","year":"2018","journal-title":"Chin J Nat Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"126780","DOI":"10.1016\/j.bmcl.2019.126780","article-title":"PEG-amino acid-przewaquinone a conjugations: Synthesis, physicochemical properties and protective effect in a rat model of brain ischemia-reperfusion","volume":"30","author":"M Wang","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"ref24","first-page":"1363","article-title":"On the quantitative analysis of focal ischemic cerebral infarction by TTC staining","volume":"26","author":"C Feng","year":"2009","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/138920008783331103","article-title":"The prediction of the hepatic clearance of tanshinone IIA in rat liver subcellular fractions: Accuracy improvement","volume":"9","author":"P Li","year":"2008","journal-title":"Curr Drug Metab"},{"volume-title":"The pharmacokinetic study of tanshinone \u2161A in rats and the involved mechanisms. [Dissertation]","year":"2007","author":"H C Bi","key":"ref26"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinchem\/26.9.1241","article-title":"Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis","volume":"26","author":"J A Lott","year":"1980","journal-title":"Clin Chem"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1748-1716.1970.tb04653.x","article-title":"Left ventricular pressure and maximum rate of pressure rise as determinants of myocardial oxygen consumption during hemorrhagic hypotension in dogs","volume":"78","author":"B Bugge-Asperheim","year":"1970","journal-title":"Acta Physiol Scand"}],"container-title":["Planta Medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2565-8285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:39:22Z","timestamp":1752230362000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2565-8285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":28,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2025,7,9]]},"published-print":{"date-parts":[[2025,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2565-8285","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0032-0943","1439-0221"],"issn-type":[{"type":"print","value":"0032-0943"},{"type":"electronic","value":"1439-0221"}],"subject":[],"published-other":{"date-parts":[[2025,3,24]]},"published":{"date-parts":[[2025,3,24]]}}}